Validation of the ICH Score in Patients with Spontaneous Intracerebral Haemorrhage Admitted to the Intensive Care Unit in Southern Spain
Overview
Authors
Affiliations
Objective: Validation of the intracerebral haemorrhage (ICH) score in patients with a diagnosis of spontaneous ICH admitted to the intensive care unit (ICU).
Methods: A multicentre cohort study was conducted in all consecutive patients with ICH admitted to the ICUs of three hospitals with a neurosurgery department between 2009 and 2012 in Andalusia, Spain. Data collected included ICH, Glasgow Coma Scale (GCS) and Acute Physiology and Chronic Health Evaluation II (APACHE-II) scores. Demographic data, location and volume of haematoma and 30-day mortality rate were also collated.
Results: A total of 336 patients were included. 105 of whom underwent surgery. Median (IQR) age: 62 (50-70) years.
Apache-ii: 21(15-26) points, GCS: 7 (4-11) points, ICH score: 2 (2-3) points. 11.1% presented with bilateral mydriasis on admission (mortality rate=100%). Intraventricular haemorrhage was observed in 58.9% of patients. In-hospital mortality was 54.17% while the APACHE-II predicted mortality was 57.22% with a standardised mortality ratio (SMR) of 0.95 (95% CI 0.81 to 1.09) and a Hosmer-Lemenshow test value (H) of 3.62 (no significant statistical difference, n.s.). 30-day mortality was 52.38% compared with the ICH score predicted mortality of 48.79%, SMR: 1.07 (95% CI 0.91 to 1.23), n.s. Mortality was higher than predicted at the lowest scores and lower than predicted in the more severe patients, (H=55.89, p<0.001), Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva calibration belt (p<0.001). The area under a receiver operating characteristic (ROC) curve was 0.74 (95% CI 0.69 to 0.79).
Conclusions: ICH score shows an acceptable discrimination as a tool to predict mortality rates in patients with spontaneous ICH admitted to the ICU, but its calibration is suboptimal.
Mao B, Ling L, Pan Y, Zhang R, Zheng W, Shen Y Sci Rep. 2024; 14(1):14195.
PMID: 38902304 PMC: 11190185. DOI: 10.1038/s41598-024-65128-8.
Gordillo-Resina M, Aranda-Martinez C, Arias-Verdu M, Guerrero-Lopez F, Castillo-Lorente E, Rodriguez-Rubio D Neurocrit Care. 2024; 41(2):583-597.
PMID: 38589693 DOI: 10.1007/s12028-024-01960-0.
Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage.
Hwang D, Kim K, Muehlschlegel S, Wartenberg K, Rajajee V, Alexander S Neurocrit Care. 2023; 40(2):395-414.
PMID: 37923968 PMC: 10959839. DOI: 10.1007/s12028-023-01854-7.
Abulhasan Y, Teitelbaum J, Al-Ramadhani K, Morrison K, Angle M Neurology. 2023; 100(19):e1985-e1995.
PMID: 36927881 PMC: 10186215. DOI: 10.1212/WNL.0000000000207132.
Simon-Pimmel J, Foucher Y, Leger M, Feuillet F, Bodet-Contentin L, Cinotti R BMJ Open. 2021; 11(9):e047279.
PMID: 34548347 PMC: 8458313. DOI: 10.1136/bmjopen-2020-047279.